EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stage‐Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune‐Related Involvement in Bladder Cancer Progression

Douglas Edgard Lemes iD, Aline Áurea de Souza Santos iD, Jéssica Lopes de Oliveira iD, Henrique Roman-Ramos iD, Ana Carolina Ramos Moreno iD, Cleber Pinto Camacho iD, José Pontes-Junior iD, Humberto Dellê iD

International Journal of Urology · 2026-05 · 33 (5)

DOI: 10.1111/iju.70491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 07.05.2026. Verfasst von Douglas Edgard Lemes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Innovation and Biotechnology Laboratory, Postgraduate Program in Medicine, Universidade Nove de Julho (Uninove), São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Kynurenine, Urinary Bladder Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L‐tryptophan (Trp) metabolism through the L‐kynurenine (Kyn) pathway contributes to immune escape in neoplasms, including bladder cancer (BC). Indoleamine 2,3‐dioxygenase‐1 (IDO1) is a key enzyme, and its catabolites—Kyn, 3‐hydroxykynurenine (3HK), and 3‐hydroxyanthranilate (3HAA)—depend on other enzymes and play a crucial role in immunomodulation.

Objectives

We investigated the association between Kyn pathway enzyme expression and BC prognostic factors.

Methods

Data from 165 bc patients in the GEO DataSets were analyzed, comparing staging, tumor grade, progression, and recurrence with the expression of IDO1, arylformamidase (AFMID), kynurenine–oxoglutarate transaminase (KAT), kynureninase (KYNU), kynurenine 3‐monooxygenase (KMO), 3‐hydroxyanthranilate 3,4‐dioxygenase (HAAO), and aminocarboxymuconate‐semialdehyde decarboxylase (ACMSD). Predictive genes were further evaluated in RT4 (low‐grade, non‐invasive) and T24 (high‐grade, invasive) BC cells treated with IFN‐gamma and the IDO1 inhibitor INCB024360. Trp catabolites were quantified in the supernatant.

Results

Enzyme expression varied widely, especially for IDO1, AFMID, KAT, KMO, and KYNU. IDO1 correlated positively with KMO and negatively with KAT. High IDO1 and KMO levels were linked to advanced‐stage disease, while KAT and KYNU were associated with earlier stages and lower tumor grade. RT4 and T24 cells showed distinct basal enzyme expression, with T24 cells being more responsive to IFN‐gamma, increasing IDO1 and KYNU while decreasing KAT and KMO. These effects were inhibited by INCB024360. High Trp consumption increased Kyn and 3HAA but not 3HK.

Conclusions

Kyn pathway enzyme expression varies with disease progression and may indicate immune activity by influencing tumor microenvironment catabolites. BC cell sensitivity to immune stimuli differs, potentially shaping distinct immune escape mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KynurenineUrinary Bladder NeoplasmsNeoplasm Recurrence, LocalHumansIndoleamine-Pyrrole 2,3,-DioxygenaseDisease ProgressionNeoplasm StagingFemaleHydrolasesTryptophanTransaminasesMaleArylformamidasePrognosis3-Hydroxyanthranilic AcidTumor EscapeNeoplasm GradingNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

bladder cancerimmuno escapeindoleamine 2,3‐dioxygenase‐1kynureninetryptophan

Substanzen

KynurenineIndoleamine-Pyrrole 2,3,-DioxygenasekynureninaseHydrolasesTryptophanIDO1 protein, humanTransaminaseskynurenine-oxoglutarate transaminaseArylformamidase3-Hydroxyanthranilic Acid

Autor:innen und Institutionen

  • Molecular Innovation and Biotechnology Laboratory, Postgraduate Program in Medicine, Universidade Nove de Julho (Uninove), São Paulo, SP, Brazil.
  • Vaccine Development Laboratory, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
  • Vaccine Development Laboratory, Butantan Institute, São Paulo, SP, Brazil.
  • Thyroid Diseases Center, Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Urology Department, LIM/55 - Laboratory of urology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, São Paulo, SP, Braz…

ORCID-Profile: Douglas Edgard Lemes, Aline Áurea de Souza Santos, Jéssica Lopes de Oliveira, Henrique Roman-Ramos, Ana Carolina Ramos Moreno, Cleber Pinto Camacho, José Pontes-Junior, Humberto Dellê

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Lemes, D. E., Santos, A. Á. S., de Oliveira, J. L., Roman-Ramos, H., Moreno, A. C. R., Camacho, C. P., Pontes-Junior, J., & Dellê, H. (2026). Stage‐Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune‐Related Involvement in Bladder Cancer Progression. International Journal of Urology, 33(5). https://doi.org/10.1111/iju.70491

Vancouver

Lemes DE, Santos AÁS, de Oliveira JL, Roman-Ramos H, Moreno ACR, Camacho CP, et al. Stage‐Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune‐Related Involvement in Bladder Cancer Progression. International Journal of Urology. 2026;33(5). doi:10.1111/iju.70491

BibTeX
@article{Lemes2026,
  author = {Lemes, Douglas Edgard and Santos, Aline Áurea de Souza and de Oliveira, Jéssica Lopes and Roman-Ramos, Henrique and Moreno, Ana Carolina Ramos and Camacho, Cleber Pinto and Pontes-Junior, José and Dellê, Humberto},
  title = {Stage‐Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune‐Related Involvement in Bladder Cancer Progression},
  journal = {International Journal of Urology},
  year = {2026},
  volume = {33},
  number = {5},
  doi = {10.1111/iju.70491}
}
Kostenlos starten →